Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Malcolm Kendrick"'
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0205138 (2019)
Statins have been prescribed for primary prevention of cardiovascular disease (CVD) for nearly 3 decades. Throughout this period key opinion leaders in the field have been dismayed by the high rate of non-adherence of patients to follow their statin
Externí odkaz:
https://doaj.org/article/9c5fd81d41a044cda9355ce0686b030f
Autor:
Malcolm Kendrick
Publikováno v:
Current opinion in endocrinology, diabetes, and obesity. 29(5)
The low-density lipoprotein (LDL)-cholesterol level is a weak predictor of developing cardiovascular (CV) disease and can only explain a small proportion of CV risk. It is not used to determine CV risk on either the atherosclerotic cardiovascular dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3392c85b884cd838c04dbbf826a2b9ef
https://pubmed.ncbi.nlm.nih.gov/35938775
https://pubmed.ncbi.nlm.nih.gov/35938775
Autor:
Peter H Langsjoen, Abdullah A Alabdulgader, David M. Diamond, Uffe Ravnskov, Sherif Sultan, Malcolm Kendrick, Tomohito Hamazaki, Kilmer S. McCully, Rokuro Hama, Michel de Lorgeril, Zoë Harcombe, Harumi Okuyama, Björn Hammarskjöld, Ralf Sundberg
Publikováno v:
Expert Review of Clinical Pharmacology. 13:1289-1294
Introduction: The European Society of Cardiology and European Atherosclerosis Society (ESC/EAS) have recently published three major revisions of their guidelines for the management of chronic heart disease, blood lipids, and diabetes. Areas covered:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f72fae7b691d73f4b1941b381ccf5b3c
https://doi.org/10.1080/17512433.2020.1841635
https://doi.org/10.1080/17512433.2020.1841635
Autor:
Jeff S. Volek, Abdullah A Alabdulgader, Zoë Harcombe, Uffe Ravnskov, Blair J. O'Neill, Sherif Sultan, Malcolm Kendrick, Michel de Lorgeril, David M. Diamond, Aseem Malhotra
Publikováno v:
BMJ Evidence-Based Medicine. 26:295-301
We have evaluated dietary recommendations for people diagnosed with familial hypercholesterolaemia (FH), a genetic condition in which increased low-density lipoprotein cholesterol (LDL-C) is associated with an increased risk for coronary heart diseas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23f4b91c7389d6f5effacafa3b127f5f
https://doi.org/10.1136/bmjebm-2020-111412
https://doi.org/10.1136/bmjebm-2020-111412
Publikováno v:
Expert review of clinical pharmacology. 14(3)
Recently, Polychronopoulos and Tziomalos reviewed research on the use of inclisiran and bempedoic acid in the management of cardiovascular disease (CVD) risk in people with familial hypercholesterolemia (FH). Their treatment recommendations were base
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddaf857270d975b8197f92fd4a449e28
https://pubmed.ncbi.nlm.nih.gov/33070644
https://pubmed.ncbi.nlm.nih.gov/33070644
Autor:
Harumi Okuyama, Niamh Hynes, Tore Scherstén, David M. Diamond, Uffe Ravnskov, Michel de Lorgeril, Rokuro Hama, Peter H Langsjoen, Paul J. Rosch, Sherif Sultan, Malcolm Kendrick, Ralf Sundberg, Kilmer S. McCully, Tomohito Hamazaki, Luca Mascitelli, Björn Hammarskjöld
Publikováno v:
Expert Review of Clinical Pharmacology. 11:959-970
For half a century, a high level of total cholesterol (TC) or low-density lipoprotein cholesterol (LDL-C) has been considered to be the major cause of atherosclerosis and cardiovascular disease (CVD), and statin treatment has been widely promoted for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55fc71f12dfb4df36b902d9344b21048
https://doi.org/10.1080/17512433.2018.1519391
https://doi.org/10.1080/17512433.2018.1519391
Publikováno v:
Medical hypotheses. 121
High low-density-lipoprotein cholesterol (LDL-C) is routinely described as the main cause of cardiovascular disease (CVD) in familial hypercholesterolemia (FH). However, numerous observations are in conflict with Bradford Hill's criteria for causalit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f26eabc616d728afb35d04e62ad7bd9f
https://pubmed.ncbi.nlm.nih.gov/30396495
https://pubmed.ncbi.nlm.nih.gov/30396495
Autor:
Ralf Sundberg, Harumi Okuyama, Luca Mascitelli, Paul J. Rosch, Malcolm Kendrick, Kilmer S. McCully, Peter H Langsjoen, Björn Hammarskjöld, Tomohito Hamazaki, Michel de Lorgeril, Rokuro Hama, Tore Scherstén, David M. Diamond, Niamh Hynes, Sherif Sultan, Uffe Ravnskov
Publikováno v:
Expert Review of Clinical Pharmacology. 12:93-94
We thank the authors for their interest in our paper and wish to expand upon the issues they raised in their letter. Our paper presents strong arguments against the general view that high LDL-chole...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c31f60d1ff480d0c79fa0dadc1f0956a
https://doi.org/10.1080/17512433.2019.1561102
https://doi.org/10.1080/17512433.2019.1561102
Autor:
Dr Malcolm Kendrick
If you have been told that you must take statins or risk a devastating heart attack or stroke, you need to read this book. Dr Kendrick, a well-known statin sceptic and author of the bestselling The Great Cholesterol Con, has returned to the diet-hear
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0205138 (2019)
PLoS ONE
PLoS ONE
Introduction Previous research has shown that statin adherence for the primary prevention of CVD is lower compared to secondary prevention populations. Therefore the aim of this systematic review was to review predictors of statin adherence for the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::459cd14586f532ebe408e00283fd526a
https://doi.org/10.1371/journal.pone.0205138
https://doi.org/10.1371/journal.pone.0205138